General form of registration statement for all companies including face-amount certificate companies

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 12 Months Ended 66 Months Ended 69 Months Ended
Mar. 31, 2011
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Dec. 31, 2011
Mar. 31, 2012
Cash flows from operating activities:            
Net loss $ (22,543) $ (36,360) $ (9,982) $ (3,666) $ (56,574) $ (63,130)
Adjustments to reconcile net loss to net cash used in operating activities:            
Stock-based compensation expense 210 1,469 2,329 39 3,874 4,748
Acquired in-process research and development 20,706 20,706     20,706 20,706
Noncash interest     236 493 1,031 1,031
Noncash interest-related parties     34 101 286 286
Contribution of services by stockholder 10 30 40 40 130 130
Issuance of Common Stock to non-employee for services     121   121 121
Change in fair value of common stock warrant liability     234   234 234
Change in fair value of embedded conversion feature     831   831 831
Change in fair value of preferred stock warrant liability   1,407     1,407 1,407
Amortization of deferred financing costs     157 415 737 737
Depreciation expense 2 22 5 5 41 41
Changes in operating assets and liabilities:            
Other current assets (28) (160) (51) 203 (215) (308)
Interest payable-related parties 18 19 (38) 38 19 19
Accounts payable and accrued expenses-related parties   (46) 46      
Accounts payable and accrued expenses (159) 1,961 361 (19) 3,474 3,824
Net cash used in operating activities (1,784) (10,952) (5,677) (2,351) (23,898) (29,323)
Cash flows from investing activities:            
Purchase of computer equipment     (13) (2) (41) (41)
Purchase of in-process research and development (3,809) (3,843)     (3,843) (3,843)
Net cash used in investing activities (3,809) (3,843) (13) (2) (3,884) (3,884)
Cash flows from financing activities:            
Proceeds from PCP notes payable-related party       570 570 570
Payment of PCP notes payable-related party     (570)   (570) (570)
Proceeds from notes payable-related parties     302 90 2,221 2,221
Proceeds from borrowings under line of credit       40 80 80
Payment of line of credit     (80)   (80) (80)
Proceeds from Senior Convertible Notes       3,500 7,570 7,570
Payment of debt issue costs       (344) (737) (737)
Payment of notes payable-related parties         (600) (600)
Proceeds from issuance of Common Stock   193     198 198
Net cash provided by financing activities   23,093 19,042 3,856 50,942 50,942
Increase in cash and cash equivalents (5,593) 8,298 13,352 1,503 23,160 17,735
Cash and cash equivalents-beginning of period 14,862 14,862 1,510 7    
Cash and cash equivalents-end of period 9,269 23,160 14,862 1,510 23,160 17,735
Supplemental disclosure of cash flow information:            
Cash paid for interest   53 81 7 141 159
Supplemental disclosure of non-cash financing and investing activities:            
Assumption of PCP Note related to Asphelia Asset Purchase 750 750     750 750
Issuance of Common Stock for Convertible Preferred Stock Series A, B and C   67,004     67,004 67,004
Series A Preferred Stock
            
Cash flows from financing activities:            
Proceeds from issuance of Convertible Preferred Stock     21,681   21,681 21,681
Payment of costs related to the issuance of Convertible Preferred Stock     (2,291)   (2,291) (2,291)
Supplemental disclosure of non-cash financing and investing activities:            
Issuance of Common Stock warrants related to the Convertible Preferred Stock Series A financing     621   621 621
Conversion of senior convertible notes principal and interest into Convertible Preferred Stock Series A     8,601   8,601 8,601
Conversion of notes payable-related parties into Convertible Preferred Stock Series A     1,907   1,907 1,907
Series B Convertible Preferred Stock
            
Supplemental disclosure of non-cash financing and investing activities:            
Issuance of Convertible Preferred Stock Series B for purchase of assets 16,114 16,114     16,114 16,114
Series C Convertible Preferred Stock
            
Cash flows from financing activities:            
Proceeds from issuance of Convertible Preferred Stock   25,784     25,784 25,784
Payment of costs related to the issuance of Convertible Preferred Stock   (2,884)     (2,884) (2,884)
Supplemental disclosure of non-cash financing and investing activities:            
Issuance of Convertible Preferred Stock Series C warrants   $ 1,286     $ 1,286 $ 1,286